Content about Meningococcal vaccine

February 5, 2014

The Centers for Disease Control and Prevention published an updated "Immunization Schedule for Adults Aged 19 Years or Older, 2014," in the Morbidity and Mortality Weekly Report.

ATLANTA — The Centers for Disease Control and Prevention on Monday published an updated "Immunization Schedule for Adults Aged 19 Years or Older, 2014," in the Morbidity and Mortality Weekly Report

December 9, 2013

Swiss drug maker Novartis is providing a vaccine to Princeton University amid an outbreak of potentially fatal meningitis that has affected at least eight students, the university said Monday.

CAMBRIDGE, Mass. — Swiss drug maker Novartis is providing a vaccine to Princeton University amid an outbreak of potentially fatal meningitis that has affected at least eight students, the university said Monday.

August 2, 2013

The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

June 13, 2013

Voices of Meningitis, a public health initiative of the National Association of School Nurses, in collaboration with Sanofi Pasteur, has announced the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease.

SILVER SPRINGS, Md. and SWIFTWATER, Pa. — Voices of Meningitis, a public health initiative of the National Association of School Nurses, in collaboration with Sanofi Pasteur, has announced the launch of Get in the Game: Keeping Teens Healthy, a new program to help educate parents on the danger and prevention of meningococcal disease.

November 7, 2011

CVS Caremark’s MinuteClinic has prepared all of its Texas-based clinics for an increased demand for the meningococcal vaccine for bacterial meningitis following a bill signed into law last May, whereby Texas will become the first state in the country to require that all college students receive one dose or booster of the meningococcal vaccine for bacterial meningitis.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has prepared all of its Texas-based clinics for an increased demand for the meningococcal vaccine for bacterial meningitis following a bill signed into law last May, whereby Texas will become the first state in the country to require that all college students receive one dose or booster of the meningococcal vaccine for bacterial meningitis. The requirement goes into effect on Jan. 1, 2012.

April 25, 2011

The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

The FDA announced the approval of Menactra, made by Sanofi Pasteur, the vaccines arm of French drug maker Sanofi-Aventis. Meningococcal disease is a life-threatening illness caused by Neisseria meningitidis bacteria that infect the bloodstream and the lining surrounding the brain and spinal cord.

October 25, 2010

An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in...

BASEL, Switzerland An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in infants, according to results of a late-stage clinical trial released Monday.

 

The Swiss drug maker said results of a phase-3 trial showed that Menveo (meningococcal group A, C, W135 and Y) induced immune responses in a high percentage of babies against four strains of the bacteria. Meningococcal disease occurs suddenly and can cause serious illness and often death during the first year of life.

 

 

August 25, 2010

The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the...

SWIFTWATER, Pa. The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the use of a vaccine in children.

Sanofi Pasteur, the vaccines division of French drug maker Sanofi-Aventis, announced Thursday the FDA’s acceptance of its application seeking approval of Menactra (meningococcal [groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine) for active immunizations of infants and toddlers against invasive meningococcal disease.